Skip to content

Clinical trials

Phase 2 Lymphoma, T-Cell, Cutaneous trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Cutaneous Phase: Phase 2 Country / region: Germany Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20052
20061
20073
20111
20151
20161
20171
20191
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Valerio Therapeutics2
4SC AG1
BioCryst Pharmaceuticals1
Celgene1
Galderma R&D1
Genmab1
Innate Pharma1
Janssen Research & Development, LLC1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Cutaneous14
Mycosis Fungoides8
Sezary Syndrome7
Lymphoma6
Lymphoma, Non-Hodgkin2
Lymphoma, T-Cell2
Ataxia Telangiectasia1
Blast Crisis1
Breast Neoplasms1
Burkitt Lymphoma1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.